Summit Therapeutics SMMT
NASDAQ SMMT
$16.75 +0.06 (+0.36%)
At close: Oct 2, 2026 · 4:00 PM EDT

Summit Therapeutics (SMMT) Gross Profit (2017 - 2020)

Updated

Summit Therapeutics (SMMT) recorded Gross Profit of -$7.6 million in Q1 2020, compared with -$7.96 million a year earlier.

Analysis

Summit Therapeutics (SMMT) Gross Profit (2017 - 2020) Analysis & Trends

On a TTM basis, Summit Therapeutics' Gross Profit came in at -$33.51 million as of Mar 31, 2020; for FY2019, it was -$32.34 million.

  • Across earlier years, Gross Profit came in at $3.55 million in FY2018, -$33.28 million in FY2017 and -$30.99 million in FY2016.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,076.25 Bn 1,044.84 Bn 19.71 Bn
2 Johnson & Johnson 617.18 Bn 535.70 Bn 17.26 Bn
3 AbbVie 464.58 Bn 437.73 Bn 12.70 Bn
4 Merck 356.04 Bn 310.47 Bn 12.21 Bn
5 Novartis Ag 269.07 Bn 224.94 Bn 11.24 Bn
6 Astrazeneca 243.21 Bn 216.77 Bn 12.86 Bn
7 Amgen 217.88 Bn 173.28 Bn 7.24 Bn
8 Gilead Sciences 179.62 Bn 153.74 Bn 6.22 Bn
9 Pfizer 158.45 Bn 105.40 Bn 10.94 Bn
10 Summit Therapeutics 13.28 Bn 11.04 Bn -
Historic Data

Historic Data

Download Data
DateValue
Mar 31, 2020 -7.60 Mn
Dec 31, 2019 -8.58 Mn
Oct 31, 2019 -9.52 Mn
Jul 31, 2019 -7.81 Mn
Mar 31, 2019 -7.96 Mn
Oct 31, 2018 -12.14 Mn
Jul 31, 2018 32.64 Mn
Apr 30, 2018 -9.24 Mn
Jan 31, 2018 -14.21 Mn
Oct 31, 2017 -6.84 Mn
Jul 31, 2017 -5.61 Mn
Apr 30, 2017 -7.17 Mn
API Access

Summit Therapeutics Gross Profit API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=gross-profit&ticker=SMMT&period=max&api_key=YOUR_API_KEY